Intana Announces Agreement to Provide Proprietary Spectroscopy Technology
15-Jul-2010 -
Intana Bioscience GmbH announced that it has entered an agreement with Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica N.V., Beerse, Belgium. Under the agreement, Intana will provide its proprietary Fluorescent Cross Correlation Spectroscopy (FCCS) ...
Belgium
inhibitors
Johnson & Johnson
+3